About This Event

embecta Corp. (embecta) (Nasdaq: EMBC), a global diabetes care company, visits the Nasdaq MarketSite in Times Square today in recognition of National Diabetes Awareness Month in November.

embecta generates $1.2B in annual revenue. embecta's history in the diabetes care category dates back to 1924 and the development of the world's first specialized insulin syringe. Today, it is a leading producer of diabetes injection devices, manufacturing approximately 8 billion injection devices annually for about 30 million patients across more than 100 countries.

In honor of the occasion, Devdatt "Dev" Kurdikar, CEO of embecta, rings the opening bell.